The department of Science and Technology has a budget estimate of ₹28,049.32 crore for 2026–27, with a notable ₹20,000 crore ...

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Traditional systems of medicine and mental health education have also received attention with the government proposing three ...

Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is ...

In the run-up to the Union Budget 2026 presentation, healthcare leaders are urging a push toward technology-driven medical ...

Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector-from its initial emergence and growth to fundamental ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

The Global Diagnostic Enzymes Market is driven by rising chronic disease prevalence requiring precise enzymatic tests and significant R&D investments in biotechnology, fostering advanced diagnostic ...

Expanding R&D in pharma and biotech, strict food safety regulations, and environmental monitoring drive chromatography market growth. Challenges include high costs limiting access for smaller entities ...